This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luzuriaga, K.
Right arrow Articles by the PACTG 356 Investigators
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luzuriaga, K.
Right arrow Articles by the PACTG 356 Investigators,

 Previous Article  |  Next Article 

Journal of Virology, January 1999, p. 362-367, Vol. 73, No. 1
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Dynamics of Human Immunodeficiency Virus Type 1 Replication in Vertically Infected Infants

Katherine Luzuriaga,1,* Hulin Wu,2 Margaret McManus,1 Paula Britto,2 William Borkowsky,3 Sandra Burchett,4 Betsy Smith,5 Lynne Mofenson,6 John L. Sullivan,1 and the PACTG 356 Investigatorsdagger

Department of Pediatrics, Program in Molecular Medicine, University of Massachusetts Medical School, Worcester,1 and Statistical and Data Analysis Center, Harvard School of Public Health,2 and Boston Children's Hospital,4 Boston, Massachusetts; Department of Pediatrics, New York University, New York, New York3; and Division of AIDS, National Institute of Allergy and Infectious Diseases,5 and Pediatric, Adolescent and Maternal AIDS Branch, National Institute of Child Health & Human Development,6 National Institutes of Health, Bethesda, Maryland

Received 24 June 1998/Accepted 8 October 1998

Plasma human immunodeficiency virus type 1 (HIV-1) turnover and kinetics were studied in children aged 15 days to 2 years following the initiation of a triple antiretroviral drug regimen consisting of zidovudine, lamivudine, and nevirapine. HIV-1 turnover was at least as rapid as that previously described in adults; turnover rates were more rapid in infants and children aged 3 months to 2 years than in infants less than 3 months of age. These data confirm the central role of HIV-1 replication in the pathogenesis of vertical HIV-1 infection and reinforce the importance of early, potent combination therapies for the long-term control of HIV-1 replication.


* Corresponding author. Mailing address: Department of Pediatrics, Program in Molecular Medicine, Room 318, Biotech 2, 373 Plantation St., Worcester, MA 01605. Phone: (508) 856-6282. Fax: (508) 856-5500. E-mail: katherine.luzuriaga{at}ummed.edu.

dagger PACTG 356 Investigators who contributed to this study include George Johnson (Medical University of South Carolina, Charleston), Hannah Gay (University of Mississippi Medical Center, Jackson), Stuart Starr (Children's Hospital, Philadelphia, Philadelphia, Pa.), Diane Wara (University of California, San Francisco, San Francisco), Yvonne Bryson (University of California, Los Angeles, Los Angeles), Colleen Cunningham (SUNY Syracuse, Syracuse, N.Y.), Ross McKinney, Jr. (Duke University Medical Center, Durham, N.C.), and Barbara Stechenberg (Baystate Medical Center, Springfield, Mass.).


Journal of Virology, January 1999, p. 362-367, Vol. 73, No. 1
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Lohman, B. L., Slyker, J. A., Richardson, B. A., Farquhar, C., Mabuka, J. M., Crudder, C., Dong, T., Obimbo, E., Mbori-Ngacha, D., Overbaugh, J., Rowland-Jones, S., John-Stewart, G. (2005). Longitudinal Assessment of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Gamma Interferon Responses during the First Year of Life in HIV-1-Infected Infants. J. Virol. 79: 8121-8130 [Abstract] [Full Text]  
  • Berk, D. R., Falkovitz-Halpern, M. S., Hill, D. W., Albin, C., Arrieta, A., Bork, J. M., Cohan, D., Nilson, B., Petru, A., Ruiz, J., Weintrub, P. S., Wenman, W., Maldonado, Y. A., for the California Pediatric HIV Study Group, (2005). Temporal Trends in Early Clinical Manifestations of Perinatal HIV Infection in a Population-Based Cohort. JAMA 293: 2221-2231 [Abstract] [Full Text]  
  • Wu, H. (2005). Statistical methods for HIV dynamic studies in AIDS clinical trials. Stat Methods Med Res 14: 171-192 [Abstract]  
  • Plipat, N., Ruan, P. K., Fenton, T., Yogev, R. (2004). Rapid Human Immunodeficiency Virus Decay in Highly Active Antiretroviral Therapy (HAART)-Experienced Children after Starting Mega-HAART. J. Virol. 78: 11272-11275 [Abstract] [Full Text]  
  • Luzuriaga, K., McManus, M., Mofenson, L., Britto, P., Graham, B., Sullivan, J. L., the PACTG 356 Investigators, (2004). A Trial of Three Antiretroviral Regimens in HIV-1-Infected Children. NEJM 350: 2471-2480 [Abstract] [Full Text]  
  • Persaud, D., Siberry, G. K., Ahonkhai, A., Kajdas, J., Monie, D., Hutton, N., Watson, D. C., Quinn, T. C., Ray, S. C., Siliciano, R. F. (2004). Continued Production of Drug-Sensitive Human Immunodeficiency Virus Type 1 in Children on Combination Antiretroviral Therapy Who Have Undetectable Viral Loads. J. Virol. 78: 968-979 [Abstract] [Full Text]  
  • Hermankova, M., Ray, S. C., Ruff, C., Powell-Davis, M., Ingersoll, R., D'Aquila, R. T., Quinn, T. C., Siliciano, J. D., Siliciano, R. F., Persaud, D. (2001). HIV-1 Drug Resistance Profiles in Children and Adults With Viral Load of <50 Copies/mL Receiving Combination Therapy. JAMA 286: 196-207 [Abstract] [Full Text]  
  • Luzuriaga, K., McManus, M., Catalina, M., Mayack, S., Sharkey, M., Stevenson, M. (2000). Early Therapy of Vertical Human Immunodeficiency Virus Type 1 (HIV-1) Infection: Control of Viral Replication and Absence of Persistent HIV-1-Specific Immune Responses. J. Virol. 74: 6984-6991 [Abstract] [Full Text]